Day-to-day repeatability of the Pulse Time Index of Norm.

IF 1.3 Q4 ENGINEERING, BIOMEDICAL Medical Devices-Evidence and Research Pub Date : 2014-02-27 eCollection Date: 2014-01-01 DOI:10.2147/MDER.S58507
Igor N Posokhov, Aleksandra O Konradi, Eugeny V Shlyakhto, Oleg V Mamontov, Artemy V Orlov, Anatoly N Rogoza
{"title":"Day-to-day repeatability of the Pulse Time Index of Norm.","authors":"Igor N Posokhov,&nbsp;Aleksandra O Konradi,&nbsp;Eugeny V Shlyakhto,&nbsp;Oleg V Mamontov,&nbsp;Artemy V Orlov,&nbsp;Anatoly N Rogoza","doi":"10.2147/MDER.S58507","DOIUrl":null,"url":null,"abstract":"<p><p>The pulse wave velocity (PWV) threshold for hypertensive target organ damage is presently set at 10 meters per second. New 24-hour monitors (eg, BPLab® and Vasotens®) provide several PWV measurements over a period of 24-72 hours. A new parameter, ie, the Pulse Time Index of Norm (PTIN), can be calculated from these data. The PTIN is defined as the percentage of a 24-hour period during which the PWV does not exceed 10 meters per second. The aim of the present study was to test the new PTIN for clinical feasibility using day-to-day repeatability analysis. Oscillometrically generated waveform files (n=85), which were previously used for research studies, were reanalyzed using the new 2013 version software of the Vasotens technology program, which enables calculation of PTIN. The intraclass correlation coefficient was 0.98 and Cronbach's alpha was 0.97, indicating that the PTIN has excellent day-to-day repeatability and internal consistency. The present results show adequate repeatability, and PTIN assessment using the Vasotens technology appears to be feasible. </p>","PeriodicalId":47140,"journal":{"name":"Medical Devices-Evidence and Research","volume":" ","pages":"29-33"},"PeriodicalIF":1.3000,"publicationDate":"2014-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/MDER.S58507","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Devices-Evidence and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/MDER.S58507","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 11

Abstract

The pulse wave velocity (PWV) threshold for hypertensive target organ damage is presently set at 10 meters per second. New 24-hour monitors (eg, BPLab® and Vasotens®) provide several PWV measurements over a period of 24-72 hours. A new parameter, ie, the Pulse Time Index of Norm (PTIN), can be calculated from these data. The PTIN is defined as the percentage of a 24-hour period during which the PWV does not exceed 10 meters per second. The aim of the present study was to test the new PTIN for clinical feasibility using day-to-day repeatability analysis. Oscillometrically generated waveform files (n=85), which were previously used for research studies, were reanalyzed using the new 2013 version software of the Vasotens technology program, which enables calculation of PTIN. The intraclass correlation coefficient was 0.98 and Cronbach's alpha was 0.97, indicating that the PTIN has excellent day-to-day repeatability and internal consistency. The present results show adequate repeatability, and PTIN assessment using the Vasotens technology appears to be feasible.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
标准脉冲时间指数的日常重复性。
高血压靶器官损伤的脉搏波速度(PWV)阈值目前设定为每秒10米。新的24小时监测仪(例如,BPLab®和Vasotens®)在24-72小时内提供几种PWV测量。从这些数据中可以计算出一个新的参数,即脉冲时间Norm指数(PTIN)。PTIN定义为24小时内PWV不超过10m / s的百分比。本研究的目的是通过日常重复性分析来测试新的PTIN的临床可行性。振荡生成的波形文件(n=85)以前用于研究,使用新的2013版Vasotens技术程序软件重新分析,该软件可以计算PTIN。类内相关系数为0.98,Cronbach’s alpha为0.97,表明PTIN具有良好的日常重复性和内部一致性。目前的结果显示出足够的可重复性,使用Vasotens技术评估PTIN似乎是可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical Devices-Evidence and Research
Medical Devices-Evidence and Research ENGINEERING, BIOMEDICAL-
CiteScore
2.80
自引率
0.00%
发文量
41
审稿时长
16 weeks
期刊最新文献
Initial Validation of the NOL Nociception Level Index® Monitoring System in Black and Multiracial People. Potential of Aluminum Drug Packages with Press-Through Packaging Considering Usability for a Wide Range of Users. The Application Effect of Fine Management Combined with Man-Machine Fixation Mode in Reducing the Attrition Rate of Laparoscopic Instruments-A Non-Randomized, Concurrent Controlled Study. Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections. May Glymphatic Drainage Improve Life Quality in Progressive Multiple Sclerosis Outpatients?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1